Angiotensin II Type 2 Receptor Stimulation Initiated After Stroke Causes Neuroprotection in Conscious Rats

No abstract is available for this paper.

• Publication year

  2012

• Venue

  HYPERTENSION

• Publication date

  2012-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/HYPERTENSIONAHA.112.199646PMID 23090772
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Angiotensin AT2 Receptor Stimulation Inhibits Early Renal Inflammation in Renovascular Hypertension

  2011cited by this paper
• The angiotensin AT2 receptor in inflammation.

  2010cited by this paper
• Neuroprotective and toxic changes in microglia in neurodegenerative disease.

  2009cited by this paper
• Expression of angiotensin II and its receptors in the normal and hypoxic amoeboid microglial cells and murine BV-2 cells.

  2009cited by this paper
• Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage

  2009cited by this paper
• Candesartan pretreatment is cerebroprotective in a rat model of endothelin‐1‐induced middle cerebral artery occlusion

  2009cited by this paper
• Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke

  2009cited by this paper
• Using behaviour to predict stroke severity in conscious rats: post-stroke treatment with 3', 4'-dihydroxyflavonol improves recovery.

  2008cited by this paper
• Early increase of Nox4 NADPH oxidase and superoxide generation following endothelin‐1‐induced stroke in conscious rats

  2008cited by this paper
• Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors

  2008cited by this paper
• AT2 receptors: Functional relevance in cardiovascular disease

  2008cited by this paper
• Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1.

  2007cited by this paper
• Neuroprotective Effect of Exogenous Microglia in Global Brain Ischemia

  2007cited by this paper
• Proliferating Resident Microglia after Focal Cerebral Ischaemia in Mice

  2007cited by this paper
• Angiotensin II Type-2 Receptor Stimulation Prevents Neural Damage by Transcriptional Activation of Methyl Methanesulfonate Sensitive 2

  2006cited by this paper
• Morbidity and Mortality After Stroke, Eprosartan Compared With Nitrendipine for Secondary Prevention: Principal Results of a Prospective Randomized Controlled Study (MOSES)

  2005cited by this paper
• Angiotensin AT2 receptor protects against cerebral ischemia‐induced neuronal injury

  2005cited by this paper
• Neuroprotective effects of candesartan against cerebral ischemia in spontaneously hypertensive rats

  2005cited by this paper
• Candesartan reduces superoxide production after global cerebral ischemia

  2005cited by this paper
• Constrictor and Dilator Effects of Angiotensin II on Cerebral Arterioles

  2005cited by this paper
• Neuroprotective Properties of Different Anesthetics on Axotomized Rat Retinal Ganglion Cells In Vivo

  2004cited by this paper
• Sustained Blockade of Brain AT1 Receptors before and after Focal Cerebral Ischemia Alleviates Neurologic Deficits and Reduces Neuronal Injury, Apoptosis, and Inflammatory Responses in the Rat

  2004cited by this paper
• Non-angiotensin II [(125)I] CGP42112 binding is a sensitive marker of neuronal injury in brainstem following unilateral nodose ganglionectomy: comparison with markers for activated microglia.

  2004cited by this paper
• Possible Inhibition of Focal Cerebral Ischemia by Angiotensin II Type 2 Receptor Stimulation

  2004cited by this paper
• International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels

  2003cited by this paper
• Accelerated Glial Reactivity to Stroke in Aged Rats Correlates with Reduced Functional Recovery

  2003cited by this paper
• AM-36, a novel neuroprotective agent, profoundly reduces reactive oxygen species formation and dopamine release in the striatum of conscious rats after endothelin-1-induced middle cerebral artery occlusion.

  2003cited by this paper
• Chronic pretreatment with candesartan improves recovery from focal cerebral ischaemia in rats

  2003cited by this paper
• Update on the treatment and prevention of ischaemic stroke

  2003cited by this paper
• Hans Link Occlusion in the Rat Dendritic Cells Are Present in Ischemic Brain After Permanent Middle Cerebral Artery

  2002cited by this paper
• Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

  2002cited by this paper
• A novel, rapid, computerised method for quantitation of neuronal damage in a rat model of stroke

  2000cited by this paper
• International union of pharmacology. XXIII. The angiotensin II receptors.

  2000cited by this paper
• Blockade of central angiotensin AT(1) receptors improves neurological outcome and reduces expression of AP-1 transcription factors after focal brain ischemia in rats.

  1999cited by this paper
• Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin-1-induced middle cerebral artery occlusion in conscious rats.

  1999cited by this paper
• Phagocytic response in photochemically induced infarction of rat cerebral cortex. The role of resident microglia.

  1997cited by this paper
• A simple versatile method for measuring tail cuff systolic blood pressure in conscious rats.

  1997cited by this paper
• Specific, non-angiotensin, [125I]CGP 42112 binding sites in rat spleen macrophages.

  1994cited by this paper
• Perivascular Microapplication of Endothelin-1: A New Model of Focal Cerebral Ischaemia in the Rat

  1993cited by this paper
• Quantitative assessment of early brain damage in a rat model of focal cerebral ischaemia.

  1987cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders.

  2026cites this paper
• Hi1a Improves Sensorimotor Deficit following Endothelin-1-Induced Stroke in Rats but Does Not Improve Functional Outcomes following Filament-Induced Stroke in Mice.

  2024cites this paper
• Inhibition of insulin-regulated aminopeptidase confers neuroprotection in a conscious model of ischemic stroke

  2023influential citation
• Microglia: The breakthrough to treat neovascularization and repair blood-retinal barrier in retinopathy

  2023influential citation
• Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain.

  2022cites this paper
• Effect of Baseline Antihypertensive Treatments on Stroke Severity and Outcomes in the BP TARGET Trial

  2022cites this paper
• Neuroprotection in Stroke—Focus on the Renin-Angiotensin System: A Systematic Review

  2022cites this paper
• The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target

  2022cites this paper
• Angiotensin-(1-9) in hypertension.

  2022cites this paper
• Contralesional angiotensin type 2 receptor activation contributes to recovery in experimental stroke.

  2022cites this paper
• AT2 activation does not influence brain damage in the early phase after experimental traumatic brain injury in male mice

  2022cites this paper
• Eprosartan: A closer insight into its neuroprotective activity in rats with focal cerebral ischemia–reperfusion injury

  2021cites this paper
• Angiotensin II Receptor Type 2 Activation Does Not In�uence Brain Damage, Neurological Impairment and In�ammation After Experimental Traumatic Brain Injury

  2021cites this paper
• Mechanisms Involved in Superiority of Angiotensin Receptor Blockade over ACE Inhibition in Attenuating Neuropathic Pain Induced in Rats

  2020cites this paper
• Emerging role of angiotensin AT2 receptor in anti-inflammation: an update.

  2020cites this paper
• The counter regulatory axis of the renin angiotensin system in the brain and ischaemic stroke: Insight from preclinical stroke studies and therapeutic potential

  2020cites this paper
• Central Application of Aliskiren, a Renin Inhibitor, Improves Outcome After Experimental Stroke Independent of Its Blood Pressure Lowering Effect

  2019cites this paper
• Nateglinide Exerts Neuroprotective Effects via Downregulation of HIF-1α/TIM-3 Inflammatory Pathway and Promotion of Caveolin-1 Expression in the Rat’s Hippocampus Subjected to Focal Cerebral Ischemia/Reperfusion Injury

  2019cites this paper
• Protective effects of the angiotensin II AT2 receptor agonist compound 21 in ischemic stroke: a nose-to-brain delivery approach.

  2018cites this paper
• Neuroprotection via AT2 receptor agonists in ischemic stroke.

  2018cites this paper
• Effects of Neuroprotectants Before and After Stroke: Statins and Anti-hypertensives

  2017cites this paper
• AT2 receptor agonist Compound 21: A silver lining for diabetic nephropathy

  2017cites this paper
• Post-stroke angiotensin II type 2 receptor activation provides long-term neuroprotection in aged rats

  2017cites this paper
• Long‐term survival and regeneration of neuronal and vasculature cells inside the core region after ischemic stroke in adult mice

  2016cites this paper
• Therapeutic potential of the renin angiotensin system in ischaemic stroke

  2016cites this paper
• Renin-angiotensin system as a potential therapeutic target in stroke and retinopathy: experimental and clinical evidence.

  2016cites this paper
• Angiotensin AT2-receptor stimulation improves survival and neurological outcome after experimental stroke in mice

  2016cites this paper
• Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system

  2016cites this paper
• Relationship between pre-stroke cardiovascular medication use and stroke severity

  2016cites this paper
• Neuroprotective effect of angiotensin II type 2 receptor during cerebral ischemia/reperfusion

  2016cites this paper
• Gender-Specific Association between Angiotensin II Type 2 Receptor -1332 A/G Gene Polymorphism and Advanced Carotid Atherosclerosis.

  2016cites this paper
• Angiotensin type 2 receptors: blood pressure regulation and end organ damage.

  2015cites this paper
• Neuroprotective Mechanisms of the ACE2–Angiotensin-(1-7)–Mas Axis in Stroke

  2015cites this paper
• Molecular programs induced by heat acclimation confer neuroprotection against TBI and hypoxic insults via cross-tolerance mechanisms

  2015cites this paper
• Effect of a Selective Mas Receptor Agonist in Cerebral Ischemia In Vitro and In Vivo

  2015cites this paper
• Direct angiotensin type 2 receptor (AT2R) stimulation attenuates T-cell and microglia activation and prevents demyelination in experimental autoimmune encephalomyelitis in mice.

  2015cites this paper
• Compound 21 is pro-angiogenic in the brain and results in sustained recovery after ischemic stroke

  2015cites this paper
• The AT2 Receptor and Inflammation

  2015cites this paper
• PcTx1 affords neuroprotection in a conscious model of stroke in hypertensive rats via selective inhibition of ASIC1a.

  2015influential citation
• The implications of angiotensin-converting enzymes and their modulators in neurodegenerative disorders: current and future perspectives.

  2015cites this paper
• Neuropeptides: Metabolism to Bioactive Fragments and the Pharmacology of Their Receptors

  2015cites this paper
• Angiotensin II protects cortical neurons against oxygen-glucose deprivation-induced injury in vitro.

  2014cites this paper
• Renin–angiotensin system in pain: Existing in a double life?

  2014cites this paper
• Sex-Dependent Effects of G Protein–Coupled Estrogen Receptor Activity on Outcome After Ischemic Stroke

  2014cites this paper
• Direct stimulation of angiotensin II type 2 receptor initiated after stroke ameliorates ischemic brain damage.

  2014cites this paper
• The Protective Arms of the Renin-Angiontensin System in Stroke

  2014cites this paper
• Angiotensin Receptor Type 2 Activation Induces Neuroprotection and Neurogenesis After Traumatic Brain Injury

  2014cites this paper
• Direct Angiotensin AT2 Receptor Stimulation Using a Novel AT2 Receptor Agonist, Compound 21, Evokes Neuroprotection in Conscious Hypertensive Rats

  2014cites this paper
• The angiotensin type 2 receptor agonist Compound 21 elicits cerebroprotection in endothelin-1 induced ischemic stroke.

  2014influential citation
• AT2 Receptor and Tissue Injury: Therapeutic Implications

  2014cites this paper
• Neuroprotection after Traumatic Brain Injury in Heat-Acclimated Mice Involves Induced Neurogenesis and Activation of Angiotensin Receptor Type 2 Signaling

  2014cites this paper
• Protective arms of the renin–angiotensin‐system in neurological disease

  2013cites this paper
• Update on the Angiotensin AT2 Receptor

  2013cites this paper
• Newly discovered components and actions of the renin-angiotensin system.

  2013cites this paper
• The role of the angiotensin AT2 receptor on the diurnal variations of nociception and motor coordination in rats.

  2013cites this paper
• Angiotensin II type 2 receptor agonists as therapies for ischemic stroke.

  2012cites this paper
• Transient filament occlusion of the middle cerebral artery in rats: does the reperfusion method matter 24 hours after perfusion?

  2012cites this paper